These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 9815783

  • 1. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers.
    Nishio M, Koshikawa T, Yatabe Y, Kuroishi T, Suyama M, Nagatake M, Sugiura T, Ariyoshi Y, Mitsudomi T, Takahashi T.
    Clin Cancer Res; 1997 Jul; 3(7):1051-8. PubMed ID: 9815783
    [Abstract] [Full Text] [Related]

  • 2. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
    Brambilla E, Moro D, Gazzeri S, Brambilla C.
    J Pathol; 1999 Aug; 188(4):351-60. PubMed ID: 10440744
    [Abstract] [Full Text] [Related]

  • 3. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H, Hu SX, Fujino M, Harada M, Kinoshita I, Xu HJ, Kuzumaki N, Kawakami Y, Benedict WF.
    Cancer; 1997 Apr 01; 79(7):1329-37. PubMed ID: 9083154
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of p27KIP1 expression in resected non-small cell lung cancers: analysis in combination with expressions of p16INK4A, pRB, and p53.
    Hirabayashi H, Ohta M, Tanaka H, Sakaguchi M, Fujii Y, Miyoshi S, Matsuda H.
    J Surg Oncol; 2002 Dec 01; 81(4):177-84; discussion 184. PubMed ID: 12451621
    [Abstract] [Full Text] [Related]

  • 5. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.
    Burke L, Flieder DB, Guinee DG, Brambilla E, Freedman AN, Bennett WP, Jones RT, Borkowski A, Caporaso NA, Fleming M, Trastek V, Pairolero P, Tazelaar H, Midthun D, Jett JR, Liotta LA, Travis WD, Harris CC.
    Clin Cancer Res; 2005 Jan 01; 11(1):232-41. PubMed ID: 15671551
    [Abstract] [Full Text] [Related]

  • 6. A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis.
    Dosaka-Akita H, Hommura F, Mishina T, Ogura S, Shimizu M, Katoh H, Kawakami Y.
    Cancer Res; 2001 Mar 15; 61(6):2500-4. PubMed ID: 11289121
    [Abstract] [Full Text] [Related]

  • 7. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M.
    Oncogene; 1998 May 14; 16(19):2469-77. PubMed ID: 9627113
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F, Dosaka-Akita H, Mishina T, Nishi M, Kojima T, Hiroumi H, Ogura S, Shimizu M, Katoh H, Kawakami Y.
    Clin Cancer Res; 2000 Oct 14; 6(10):4073-81. PubMed ID: 11051259
    [Abstract] [Full Text] [Related]

  • 9. Cyclin E expression, a potential prognostic marker for non-small cell lung cancers.
    Mishina T, Dosaka-Akita H, Hommura F, Nishi M, Kojima T, Ogura S, Shimizu M, Katoh H, Kawakami Y.
    Clin Cancer Res; 2000 Jan 14; 6(1):11-6. PubMed ID: 10656426
    [Abstract] [Full Text] [Related]

  • 10. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S, Yasufuku K, Hiroshima K, Nakajima T, Yoshida S, Suzuki M, Sekine Y, Shibuya K, Iizasa T, Farouk A, Fujisawa T.
    Cancer; 2007 Jun 15; 109(12):2506-14. PubMed ID: 17487846
    [Abstract] [Full Text] [Related]

  • 11. RB growth control evasion in lung cancer.
    Caputi M, Esposito V, Groger AM, De Luca A, Pacilio C, Dekan G, Giordano GG, Baldi F, Wolner E, Giordano A.
    Anticancer Res; 1998 Jun 15; 18(4A):2371-4. PubMed ID: 9703881
    [Abstract] [Full Text] [Related]

  • 12. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
    Vielba R, Bilbao J, Ispizua A, Zabalza I, Alfaro J, Rezola R, Moreno E, Elorriaga J, Alonso I, Baroja A, de la Hoz C.
    Laryngoscope; 2003 Jan 15; 113(1):167-72. PubMed ID: 12514403
    [Abstract] [Full Text] [Related]

  • 13. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.
    Bova RJ, Quinn DI, Nankervis JS, Cole IE, Sheridan BF, Jensen MJ, Morgan GJ, Hughes CJ, Sutherland RL.
    Clin Cancer Res; 1999 Oct 15; 5(10):2810-9. PubMed ID: 10537346
    [Abstract] [Full Text] [Related]

  • 14. The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung.
    Anton RC, Coffey DM, Gondo MM, Stephenson MA, Brown RW, Cagle PT.
    Mod Pathol; 2000 Nov 15; 13(11):1167-72. PubMed ID: 11106072
    [Abstract] [Full Text] [Related]

  • 15. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
    Geradts J, Fong KM, Zimmerman PV, Maynard R, Minna JD.
    Clin Cancer Res; 1999 Apr 15; 5(4):791-800. PubMed ID: 10213214
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M, Merk J, Stoehr R, Schaeper F, Gaumann A, Wiebe K, Hartmann A, Hofstaedter F, Dietmaier W.
    Hum Pathol; 2008 Jan 15; 39(1):126-36. PubMed ID: 17949785
    [Abstract] [Full Text] [Related]

  • 17. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study.
    Fernando HC, Sasatomi E, Christie NA, Buenaventura PO, Finkelstein SD, Yousem SA, Soose R, Close JM, Luketich JD.
    J Thorac Cardiovasc Surg; 2004 Jan 15; 127(1):87-91. PubMed ID: 14752417
    [Abstract] [Full Text] [Related]

  • 18. Expression of cyclin D1 but not of cyclin E is an indicator of poor prognosis in small adenocarcinomas of the lung.
    Ikehara M, Oshita F, Ito H, Ohgane N, Suzuki R, Saito H, Yamada K, Noda K, Mitsuda A, Kameda Y.
    Oncol Rep; 2003 Jan 15; 10(1):137-9. PubMed ID: 12469159
    [Abstract] [Full Text] [Related]

  • 19. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 15; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 20. Altered retinoblastoma and p53 protein status in non-small cell carcinoma of the lung: potential synergistic effects on prognosis.
    Xu HJ, Cagle PT, Hu SX, Li J, Benedict WF.
    Clin Cancer Res; 1996 Jul 15; 2(7):1169-76. PubMed ID: 9816284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.